- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03026699
Refining and Testing the Electronic Social Network Assessment Program (eSNAP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Former Aim 1: Refine eSNAP data-gathering and visualization prototypes based on evaluations of user experience, including usability, satisfaction and applicability. The refining process was completed at the University of Utah.
Aim 2: Test the feasibility of implementing eSNAP in a neuro-oncology clinical setting and collect preliminary effectiveness data of eSNAP on Family Caregiver outcomes, including quality of life and stress, and mediators (Family Caregiver social support utilization and burden). The feasibility process will take place at Moffitt Cancer Center.
This study will be a 2x2 longitudinal design. Caregivers of primary brain tumor patients will be compared to caregivers of patients with secondary brain tumors (brain metastases) to determine if there is something unique about the cancer-specific duties of primary versus secondary brain tumors that could impact the effectiveness of the eSNAP application. An intervention group will be compared to a control group for both types of caregivers. Participants will be randomized 2:1 for the intervention and control. All caregivers will be followed for 6 weeks and will be asked to complete questionnaires at 3 time points; caregivers in the intervention group will also be asked to use the eSNAP application at time 1, which will be available to them for the duration of the study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- H. Lee Moffitt Cancer Center and Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Family caregiver of a patient with primary or secondary brain tumor
- Age 18 years or older
- Able to speak and write English
Exclusion Criteria:
- Does not meet the Inclusion Criteria
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intervention - Primary Brain Tumor
eSNAP Intervention Plus Questionnaires: Family caregivers of primary brain tumor patients.
|
Participants in the intervention group will then be given a tablet loaded with the eSNAP application and asked to create a visualization of their social networks.
Upon completion, participants will be asked to review their ecomaps and complete the user experience questionnaire.
Other Names:
Participants will complete demographics and baseline (T1; baseline) questionnaires.
For all participants Time 2 (T2; 3 week) and Time 3 (T3; 6 week) questionnaires will be completed either by phone, mail, or email (depending on participant preference) to assess longer-term effects of eSNAP on outcomes versus controls.
|
Intervention - Secondary Brain Tumor
eSNAP Intervention Plus Questionnaires: Family caregivers of secondary brain tumor patients.
|
Participants in the intervention group will then be given a tablet loaded with the eSNAP application and asked to create a visualization of their social networks.
Upon completion, participants will be asked to review their ecomaps and complete the user experience questionnaire.
Other Names:
Participants will complete demographics and baseline (T1; baseline) questionnaires.
For all participants Time 2 (T2; 3 week) and Time 3 (T3; 6 week) questionnaires will be completed either by phone, mail, or email (depending on participant preference) to assess longer-term effects of eSNAP on outcomes versus controls.
|
Control - Primary Brain Tumor
Questionnaires Only Control: Family caregivers of primary brain tumor patients.
|
Participants will complete demographics and baseline (T1; baseline) questionnaires.
For all participants Time 2 (T2; 3 week) and Time 3 (T3; 6 week) questionnaires will be completed either by phone, mail, or email (depending on participant preference) to assess longer-term effects of eSNAP on outcomes versus controls.
|
Control - Secondary Brain Tumor
Questionnaires Only Control: Family caregivers of secondary brain tumor patients.
|
Participants will complete demographics and baseline (T1; baseline) questionnaires.
For all participants Time 2 (T2; 3 week) and Time 3 (T3; 6 week) questionnaires will be completed either by phone, mail, or email (depending on participant preference) to assess longer-term effects of eSNAP on outcomes versus controls.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Questionnaire Participation Among Participant Groups
Time Frame: 6 weeks per participant
|
Feasibility 1: Recruitment rates per group.
|
6 weeks per participant
|
Retention of Participants Among Participant Groups
Time Frame: 6 weeks per participant
|
Feasibility 2: Retention rates per group.
|
6 weeks per participant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stress and Coping - Quality of Life Among Participant Groups
Time Frame: 6 weeks per participant
|
Although not reaching adequate power to detect differences, planned analysis will allow investigators to estimate effect size of eSNAP at baseline as well as the effect of cancer type.
(Power analysis conducted in G*Power for ANOVA using effect size 0.2 a=.05 for 3 groups for power of 0.80 requires a sample of 246.) ANOVA will be conducted to determine if groups vary on stress and quality of life at baseline.
Growth-curve analysis will be used to identify potential preliminary differences in the eSNAP group over time.
|
6 weeks per participant
|
Perceived Social Support - Quality of Life Among Participant Groups
Time Frame: 6 weeks per participant
|
Chi square and generalized linear model (GLM) will be used to analyze utilization of support services differences.
|
6 weeks per participant
|
Incidence of Clinic Disruption
Time Frame: 6 weeks per participant
|
Incidence of clinic disruption per participant group.
|
6 weeks per participant
|
Incidence of Problems with eSNAP implementation
Time Frame: 6 weeks per participant
|
Chi square and generalized linear model (GLM) will be used to analyze trends in satisfaction or time spent on ecomapping/eSNAP.
|
6 weeks per participant
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Maija Reblin, Ph.D., H. Lee Moffitt Cancer Center and Research Institute
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MCC-18378
- R03CA201684-01 (NIH)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownCancer | Metastatic Cancer | Metastatic Brain CancerChina
-
University of FloridaCompletedBrain Neoplasms | Brain Cancer | Brain Tumors | Seizure | Cancer of the Brain | Cancer of BrainUnited States
-
Eisai Inc.CompletedMetastatic Brain CancerUnited States
-
Sunnybrook Health Sciences CentreActive, not recruitingBreast Cancer | Head and Neck Cancer | Gynecologic Cancer | Brain CancerCanada
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
InSightecActive, not recruitingGlioma | Metastatic Brain CancerCanada
-
Virginia Commonwealth UniversityUnited States Department of DefenseActive, not recruitingBrain Metastases, Adult | Cancer Metastatic to BrainUnited States
-
Institut National de la Santé Et de la Recherche...RecruitingPediatric Cancer | Cancer BrainFrance
Clinical Trials on eSNAP
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingBrain CancerUnited States